The primary feature of stepper motors is listed right within their name: their ability to ‘step’ forwards and backwards, ...
UK-based Verona Pharma has scored a key win in a phase 3 trial of its chronic obstructive pulmonary disease (COPD) drug ensifentrine, setting up regulatory filings in the first half of next year.
It is playing catch-up with a rival Lp(a) targeting antisense drug from Novartis and development partner Akcea, called pelacarsen, which is already in a phase 3 trial called HORIZON with major ...
2025 is going to be Doechii's year - but who is she?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback